Azacitidine 16729-0306
Product NDC
16729-0306- Manufacturer
- Accord Healthcare Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 9, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA207475
Need to source Azacitidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Azacitidine | 100 mg/1 |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(1)
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16729-306-10)